Myelodysplastic Syndromes Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Neoplasms
  • +2 more
  • Bortezomib plus Clofarabine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
M
Recruiting
  • Myelodysplastic Syndromes
  • Next Generation Sequencing
  • +5 more
  • Innsbruck, Tyrol, Austria
    Medical University of Innsbruck
2022-04-06
Apr 6, 2022
W
Recruiting
  • Whole Genome Sequencing
  • +2 more
  • ChromoSeq
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-04-06
Apr 6, 2022
S
Completed
  • Acute Myeloid Leukemia
  • +8 more
  • DSP-7888 Dosing Emulsion
  • Denver, Colorado
  • +7 more
2022-04-04
Apr 4, 2022
S
Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2022-04-04
Apr 4, 2022
N
Completed
  • Acute Myelogenous Leukemia
  • +6 more
  • This is a non-interventional study
  • Bakersfield, California
  • +19 more
2022-04-04
Apr 4, 2022
T
Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2022-04-01
Apr 1, 2022
W
Active, not recruiting
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +2 more
2022-04-01
Apr 1, 2022
U
Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
2022-03-31
Mar 31, 2022
H
Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
2022-03-23
Mar 23, 2022
S
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +12 more
2022-03-23
Mar 23, 2022
P
Active, not recruiting
  • Myelodysplastic Syndromes
  • Acute Leukemia
  • Heidelberg, Baden-Württemberg, Germany
  • +4 more
2022-03-31
Mar 31, 2022
B
Recruiting
  • Brain and Central Nervous System Tumors
  • +8 more
  • 3'-deoxy-3'-[18F]fluorothymidine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2022-03-30
Mar 30, 2022
W
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Peripheral blood draw
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-30
Mar 30, 2022
K
Active, not recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Newcastle, New South Wales, Australia
  • +10 more
2022-03-29
Mar 29, 2022
C
Not yet recruiting
  • Haematological Malignancy
  • +5 more
  • Physical activity program
  • Lyon, France
    Institut d'Hématologie et d'Oncologie Pédiatrique
2022-03-25
Mar 25, 2022
C
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Ex-vivo expanded γδ T cell infusion
  • Beijing, China
    Chinese PLA General Hospital
2022-03-24
Mar 24, 2022
U
Recruiting
  • Myelodysplastic Syndromes
  • Flow cytometric analysis of neutrophil myeloperoxidase expression
  • Clermont-Ferrand, France
  • +5 more
2022-03-24
Mar 24, 2022
C
Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +18 more
2022-03-11
Mar 11, 2022
J
Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Marseille Cedex 9, France
  • +5 more
2022-03-24
Mar 24, 2022
I
Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Miami, Florida
  • +12 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Boston, Massachusetts
  • +16 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
2022-03-24
Mar 24, 2022